Treatments and Prevention of CVDs by Taking an Insight into the Mechanism of Cardiovascular Aging

Authors

  • Peijie Shi

DOI:

https://doi.org/10.54097/h2m33r10

Keywords:

Cardiovascular aging, impacts, treatments.

Abstract

In an era of rapid technological advancement, a notable and convincing demographic trend is emerging: a significant increase in the elderly population. This demographic shift is represented by numerous factors, including enhanced healthcare, medical breakthroughs, and improved living standard conditions. This transformation brings numerous concerns for the health and well-being of the elderly. This concern is particularly pronounced when considering the impact of cardiovascular aging, a critical facet of their overall health that carries substantial implications for governments and healthcare systems worldwide. However, people’s knowledge of these diseases and our ability to control epidemics is still limited. Cardiovascular aging brings many changes to our lives and poses high risks for the elderly. This report aims to analyze cardiovascular changes and combine existing medical methods to make efficient suggestions. To address the challenges posed by the aging population to cardiovascular disease, it is important to cultivate a comprehensive approach that includes risk factor management, lifestyle interventions, and advanced therapies.

Downloads

Download data is not yet available.

References

Wang C, Yuan Y, Zheng M, et al. Association of Age of Onset of Hypertension with Cardiovascular Diseases and Mortality. J Am Coll Cardiol. 2020 Jun, 75 (23) 2921–2930.

Rodgers J L, Jones J, Bolleddu S I, et al. Cardiovascular risks associated with gender and aging [J]. Journal of cardiovascular development and disease, 2019, 6 (2): 19.

Brandhorst S, Longo V D. Dietary restrictions and nutrition in the prevention and treatment of cardiovascular disease [J]. Circulation research, 2019, 124 (6): 952-965.

Cavalcante R, Sotomi Y, Zeng Y, et al. Coronary bypass surgery versus stenting in multivessel disease involving the proximal left anterior descending coronary artery [J]. Heart, 2017, 103 (6): 428-433.

World Health Organization, Cardiovascular diseases (CVDs), 2021.07.11, 2023.08.27, https://www.who.int/news-room/fact-sheets/detail/cardiovascular-diseases-(cvds).

AstraZeneca, Forxiga approved in China to reduce the risk of cardiovascular death and hospitalization in adult patients with symptomatic chronic heart failure, 2023.08.18, 2023.08.27, https://www.astrazeneca.com/media-centre/press-releases/2023/forxiga-approved-china-reduce-risk-cardiovascular-death-hospitalisation-patients-with-symptomatic-chronic-heart-failure.html.

Tran D B, Weber C, Lopez R A. Anatomy, thorax, heart muscles. 2019.

Marino F, Scalise M, Cianflone E, et al. Role of c-kit in myocardial regeneration and aging [J]. Frontiers in endocrinology, 2019, 10: 371.

Stewart M H, Lavie C J, Shah S, et al. Prognostic implications of left ventricular hypertrophy [J]. Progress in cardiovascular diseases, 2018, 61 (5-6): 446-455.

Murphy S P, Ibrahim N E, Januzzi J L. Heart failure with reduced ejection fraction: a review [J]. Jama, 2020, 324 (5): 488-504.

Mary Jones, Richard Fosbery, Dennis Taylor, Jennifer Gregory, Biology for Cambridge International AS& A Level, Cambridge University Press, Cambridge, 195-196, 2020

Cocciolone A J, Hawes J Z, Staiculescu M C, et al. Elastin, arterial mechanics, and cardiovascular disease [J]. American Journal of Physiology-Heart and Circulatory Physiology, 2018, 315 (2): H189-H205.

Heinz A. Elastic fibers during aging and disease [J]. Aging research reviews, 2021, 66: 101255.

National Heart, Lung, and Blood Institute, What Is Atherosclerosis? 2022.03.24, 2023.08.28, https://www.nhlbi.nih.gov/health/atherosclerosis.

Zhang Y, Zeng C. Role of DNA methylation in cardiovascular diseases [J]. Clinical and experimental hypertension, 2016, 38 (3): 261-267.

Xu H, Li S, Liu Y S. Roles and mechanisms of DNA methylation in vascular aging and related diseases [J]. Frontiers in Cell and Developmental Biology, 2021, 9: 699374.

Salameh Y, Bejaoui Y, El Hajj N. DNA methylation biomarkers in aging and age-related diseases [J]. Frontiers in Genetics, 2020, 11: 171.

Arrigo M, Jessup M, Mullens W, et al. Acute heart failure [J]. Nature Reviews Disease Primers, 2020, 6 (1): 16.

Kehrenberg M C A, Bachmann H S. Diuretics: a contemporary pharmacological classification? [J]. Naunyn-schmiedeberg's Archives of Pharmacology, 2022, 395 (6): 619-627.

Ares G R. Ubiquitination of NKCC2 by the cullin-RING E3 ubiquitin ligase family in the thick ascending limb of the loop of Henle [J]. American Journal of Physiology-Renal Physiology, 2023, 324 (3): F315-F328.

Mullens W, Damman K, Harjola V P, et al. The use of diuretics in heart failure with congestion—a position statement from the Heart Failure Association of the European Society of Cardiology [J]. European journal of heart failure, 2019, 21 (2): 137-155.

Mayo Clinic Staff, Angiotensin-converting enzyme (ACE) inhibitors, 2023.08.16, 2023.08.29, https://www.mayoclinic.org/diseases-conditions/high-blood-pressure/in-depth/ace-inhibitors/art-20047480.

Bachheti R K, Worku L A, Gonfa Y H, et al. Prevention and treatment of cardiovascular diseases with plant phytochemicals: A review [J]. Evidence-Based Complementary and Alternative Medicine, 2022, 2022.

Patrignani F, Prasad S, Novakovic M, et al. Lamiaceae in the treatment of cardiovascular diseases [J]. Frontiers in Bioscience-Landmark, 2020, 26 (4): 612-643.

Downloads

Published

29-12-2023